- English
- Esta página
- Página inicial
- Arabic (اللغة العربية)
- Chinese (简体中文)
- French (Français)
- Haitian Creole (Kreyòl Ayisyen)
- Hindi (जानकारी)
- Korean (한국어)
- Polish (język polski)
- Portuguese (Português)
- Russian (Русский)
- Spanish (Español)
- Tagalog (Tagalog)
- Ukrainian (Українська)
- Vietnamese (Tiếng Việt)
- All Languages
Español
PDFs by language
Our 24/7 cancer helpline provides support for people dealing with cancer. We can connect you with trained cancer information specialists who will answer questions about a cancer diagnosis and provide guidance and a compassionate ear.
Chat live online
Select the Live Chat button at the bottom of the page
At our National Cancer Information Center trained Cancer Information Specialists can answer questions 24 hours a day, every day of the year to empower you with accurate, up-to-date information to help you make educated health decisions. We connect patients, caregivers, and family members with valuable services and resources.
Or ask us how you can get involved and support the fight against cancer. Some of the topics we can assist with include:
- Referrals to patient-related programs or resources
- Donations, website, or event-related assistance
- Tobacco-related topics
- Volunteer opportunities
- Cancer Information
For medical questions, we encourage you to review our information with your doctor.
Research We Fund: Extramural Discovery Science
-
-
- RFA: Cancer Stem Cell Consortium
- RFA: Real-World Data Impact Award (RWIA)
- Research Scholar Grants
- Clinical Research Professor
- Research Professor Grants
- X Grant Application Deadlines
- Institutional Research Grants
- Postdoctoral Fellowships
- RFA: Pilot and Exploratory Projects in Palliative Care of Cancer Patients and Their Families
- RFA: The Role of Health Policy and Health Insurance in Improving Access to and Performance of Cancer Prevention, Early Detection, and Treatment Services
- The St. Baldrick's Foundation-American Cancer Society Childhood Cancer
- RFA: Metastasis in Melanoma and Other Cancers
- Clinician Scientist Development Grant (CSDG)
- Mission Boost Grants (MBG)
- Cancer Health Equity Research
- X RFA: Cancer Health Equity Research Centers
- Arizona (AZ) Discovery Boost Grants (DBG)
- ASTRO-ACS Clinician Scientist Development Grant (CSDG)
- Discovery Boost Grants (DBG)
- RFA: Screening Research Priority Area
- DICR IDG l Diversity in Cancer Research Institutional Development Grant
- AHEAD (Advancing Health Equity and Addressing Cancer Disparities) Awards
- The ACS-Wilmott Family Professorship in Pancreatic Cancer
- RFA: Cancer Health Equity Research Centers
- Grant Reporting Forms
- Extramural Grants Department Staff Contacts
- Definition of Research Areas
- FAQs: ACS Extramural Discovery Science and Grant Application Submissions
- Extramural Priority Research Areas
-
- American Cancer Society Research Events
- American Cancer Society Research and Clinical Research Professors
- Nobel Laureates and the American Cancer Society
-
- Peer Review Committee for Experimental Therapeutics (ET)
- Peer Review Committee for DNA Mechanisms in Cancer (DMC)
- Peer Review Committee for Institutional Research Grants (IRG)
- Peer Review Committee for RNA Mechanisms in Cancer (RMC)
- Peer Review Committee for Tumor Biochemistry and Endocrinology (TBE)
- Peer Review Committee for Cancer Cell Biology (CCB)
- Peer Review Committee for Cancer Detection and Progression (CDP)
- Peer Review Committee for Cancer Prevention, Screening, and Health Promotion (CPSH)
- Peer Review Committee for Healthcare Outcomes, Policy, and Systems Research (HOPS)
- Peer Review Committee for Mission Boost Grants
- Peer Review Committee for Immunology and Blood Cell Development (IBCD)
- Peer Review Committee for Treatment, Palliative Care, and Survivorship Research
- Council for Extramural Grants
- Stakeholder Participation on Grant Peer Review Committees
- Peer Review Committee for Metastasis and Microenvironment (MM)
- Peer Review Committee for Clinical Studies and Clinical Trials
Peer Review Committee for Experimental Therapeutics (ET)
Areas reviewed
- Isolation, testing, and synthesis of natural products
- Modification and development of drugs
- Toxicity and effectiveness of therapeutic agents and drug delivery systems (including nanotechnology and microbial strategies)
- Molecular imaging for pre-clinical therapeutic development
- Pharmacology/pharmacogenetics/pharmacogenomics
- Gene therapies and gene target validation
Peer Review Committee Members
Co-chair, Weibo Cai, PhD, University of Wisconsin Madison
Co-chair, Goutham Narla, MD, PhD, University of Michigan
Stakeholder, Elizabeth Naylor
Stakeholder, Nick Wendell
Raman Bahal, PhD, University of Connecticut
Chandra Bartholomeusz, MD, PhD, MD Anderson
Tomasz Cierpicki, PhD, University of Michigan
Edith Phoebe Glazer, PhD, North Carolina State University
Hanna Irie, MD, PhD, Mount Sinai
Dan Siegwart, PhD, UT Southwestern
Stavroula Sofou, PhD, Johns Hopkins University
Stephen Sykes, PhD, Washington University St. Louis
Uttam Tambar, PhD, UT Southwestern
Matt VanBrocklin, PhD, University of Utah
David Wald, MD, PhD, Case Western University